ATE82129T1 - Antiinfektioese verbindungen und verfahren zur verwendung. - Google Patents

Antiinfektioese verbindungen und verfahren zur verwendung.

Info

Publication number: ATE82129T1
Authority: AT; Austria
Prior art keywords: c2h4o; compound; present; treating; hltv
Prior art date: 1987-02-20

Application number

AT88902681T

Other languages

English (en)

Inventor

Robert L Hunter

Original Assignee

Univ Emory

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-02-20

Filing date

1988-02-19

Publication date

1992-11-15

1988-02-19 Application filed by Univ Emory filed Critical Univ Emory

1992-11-15 Application granted granted Critical

1992-11-15 Publication of ATE82129T1 publication Critical patent/ATE82129T1/de

Links

150000001875 compounds Chemical class 0.000 title abstract 4
238000000034 method Methods 0.000 title abstract 4
230000002924 anti-infective effect Effects 0.000 title 1
241000700605 Viruses Species 0.000 abstract 3
ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 abstract 2
241001465754 Metazoa Species 0.000 abstract 2
229920001577 copolymer Polymers 0.000 abstract 2
AEUTYOVWOVBAKS-UWVGGRQHSA-N ethambutol Chemical compound CC[C@@H](CO)NCCN[C@@H](CC)CO AEUTYOVWOVBAKS-UWVGGRQHSA-N 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
208000035143 Bacterial infection Diseases 0.000 abstract 1
229930182566 Gentamicin Natural products 0.000 abstract 1
CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 abstract 1
RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 abstract 1
239000004098 Tetracycline Substances 0.000 abstract 1
208000036142 Viral infection Diseases 0.000 abstract 1
239000003242 anti bacterial agent Substances 0.000 abstract 1
229940088710 antibiotic agent Drugs 0.000 abstract 1
208000022362 bacterial infectious disease Diseases 0.000 abstract 1
230000003115 biocidal effect Effects 0.000 abstract 1
229920001400 block copolymer Polymers 0.000 abstract 1
239000007859 condensation product Substances 0.000 abstract 1
229960003276 erythromycin Drugs 0.000 abstract 1
229960000285 ethambutol Drugs 0.000 abstract 1
229960002518 gentamicin Drugs 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
229960003350 isoniazid Drugs 0.000 abstract 1
QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 abstract 1
125000000963 oxybis(methylene) group Chemical group [H]C([H])(*)OC([H])([H])* 0.000 abstract 1
229960002180 tetracycline Drugs 0.000 abstract 1
229930101283 tetracycline Natural products 0.000 abstract 1
235000019364 tetracycline Nutrition 0.000 abstract 1
150000003522 tetracyclines Chemical class 0.000 abstract 1
230000009385 viral infection Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/30—Post-polymerisation treatment, e.g. recovery, purification, drying
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/77—Polymers containing oxygen of oxiranes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
General Chemical & Material Sciences (AREA)
Polymers & Plastics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
External Artificial Organs (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

AT88902681T 1987-02-20 1988-02-19 Antiinfektioese verbindungen und verfahren zur verwendung. ATE82129T1 (de)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US1733087A	1987-02-20	1987-02-20
US15073188A	1988-02-16	1988-02-16
EP88902681A EP0305470B1 (de)	1987-02-20	1988-02-19	Antiinfektiöse verbindungen und verfahren zur verwendung
PCT/US1988/000510 WO1988006038A1 (en)	1987-02-20	1988-02-19	Antiinfective compounds and method of use

Publications (1)

Publication Number	Publication Date
ATE82129T1 true ATE82129T1 (de)	1992-11-15

Family

ID=26689732

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT88902681T ATE82129T1 (de)	1987-02-20	1988-02-19	Antiinfektioese verbindungen und verfahren zur verwendung.

Country Status (9)

Country	Link
EP (1)	EP0305470B1 (de)
JP (1)	JPH01503458A (de)
AT (1)	ATE82129T1 (de)
AU (1)	AU1396588A (de)
CA (1)	CA1314221C (de)
DE (1)	DE3875871T2 (de)
DK (1)	DK582588A (de)
FI (1)	FI884850A0 (de)
WO (1)	WO1988006038A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5674911A (en) *	1987-02-20	1997-10-07	Cytrx Corporation	Antiinfective polyoxypropylene/polyoxyethylene copolymers and methods of use
CN1069741A (zh)	1991-03-19	1993-03-10	西特克斯公司	具有改进的生物活性的聚氧丙烯/聚氧乙烯共聚物
USRE38558E1 (en)	1991-03-19	2004-07-20	Cytrx Corporation	Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
US6153193A (en) *	1993-04-28	2000-11-28	Supratek Pharma Inc.	Compositions for targeting biological agents
US6093391A (en) *	1992-10-08	2000-07-25	Supratek Pharma, Inc.	Peptide copolymer compositions
US6277410B1 (en) *	1992-10-08	2001-08-21	Supratek Pharma Inc.	Copolymer compositions for oral delivery
DE69428521T2 (de) *	1993-02-02	2002-05-23	Xoma Technology Ltd	Arzneizusammensetzungen enthaltend ein bakterizides permeabilität erhöhendes protein und ein tensid
US6214789B1 (en)	1993-03-12	2001-04-10	Xoma Corporation	Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products
GB2281697A (en) *	1993-09-14	1995-03-15	Euro Celtique Sa	Laxative compositions in capsules
US5932544A (en) *	1994-05-31	1999-08-03	Xoma Corporation	Bactericidal/permeability-increasing protein (BPI) compositions
US6353055B1 (en)	1994-11-18	2002-03-05	Supratek Pharma Inc.	Polynucleotide compositions
US6221959B1 (en)	1994-11-18	2001-04-24	Supratek Pharma, Inc.	Polynucleotide compositions
RU2146130C1 (ru) *	1999-07-08	2000-03-10	Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин"	Фармацевтический состав, обладающий противотуберкулезной активностью
DE10358534A1 (de)	2003-12-13	2005-07-14	Henkel Kgaa	Adhäsionshemmung von Mikroorganismen durch nichtionische Tenside
RU2496475C2 (ru)	2011-10-26	2013-10-27	Александр Васильевич Иващенко	Фармацевтическая композиция и набор для лечения бактериальных инфекций

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2674619A (en) *	1953-10-19	1954-04-06	Wyandotte Chemicals Corp	Polyoxyalkylene compounds
US3140232A (en) *	1962-12-19	1964-07-07	Pfizer & Co C	Color stabilization of tetracycline compositions with polypropylene glycols
CA959759A (en) *	1970-01-15	1974-12-24	John J. Miskel	Method for absorption of drugs
JPS5283936A (en) *	1976-01-01	1977-07-13	Ortho Pharma Corp	Single herpes virus inactivating acent
DE2732929A1 (de) *	1977-07-21	1979-02-01	Bayer Ag	Polyaether, verfahren zu ihrer herstellung sowie ihre verwendung als lipidabsorptionshemmer
JPS5449322A (en) *	1977-09-26	1979-04-18	Daicel Chem Ind Ltd	Non-medical anti-bacterial and anti-mold agent
JPS5668616A (en) *	1979-11-08	1981-06-09	Yukio Kimura	Preparation of antibiotic composition
JPS579717A (en) *	1980-06-20	1982-01-19	Nippon Shinyaku Co Ltd	Germicidal composition
US4376118A (en) *	1980-10-06	1983-03-08	Miles Laboratories, Inc.	Stable nonaqueous solution of tetracycline salt
DE3234084A1 (de) *	1982-09-14	1984-03-15	B. Braun Melsungen Ag, 3508 Melsungen	Pharmazeutische zubereitungen zur behandlung von unerwuenschten verwachsungen sowie deren verwendung

1988
- 1988-02-19 AT AT88902681T patent/ATE82129T1/de not_active IP Right Cessation
- 1988-02-19 DE DE8888902681T patent/DE3875871T2/de not_active Expired - Fee Related
- 1988-02-19 WO PCT/US1988/000510 patent/WO1988006038A1/en not_active Ceased
- 1988-02-19 JP JP63502373A patent/JPH01503458A/ja active Pending
- 1988-02-19 EP EP88902681A patent/EP0305470B1/de not_active Expired - Lifetime
- 1988-02-19 AU AU13965/88A patent/AU1396588A/en not_active Abandoned
- 1988-02-22 CA CA000559454A patent/CA1314221C/en not_active Expired - Fee Related
- 1988-10-19 DK DK582588A patent/DK582588A/da not_active Application Discontinuation
- 1988-10-20 FI FI884850A patent/FI884850A0/fi not_active Application Discontinuation

Also Published As

Publication number	Publication date
CA1314221C (en)	1993-03-09
FI884850A7 (fi)	1988-10-20
EP0305470B1 (de)	1992-11-11
DE3875871T2 (de)	1993-04-01
DE3875871D1 (de)	1992-12-17
EP0305470A1 (de)	1989-03-08
WO1988006038A1 (en)	1988-08-25
DK582588D0 (da)	1988-10-19
JPH01503458A (ja)	1989-11-22
DK582588A (da)	1988-12-12
AU1396588A (en)	1988-09-14
FI884850A0 (fi)	1988-10-20

Similar Documents

Publication	Publication Date	Title
ATE82129T1 (de)	1992-11-15	Antiinfektioese verbindungen und verfahren zur verwendung.
Emmons et al.	1991	Rhodococcus equi infection in the patient with AIDS: literature review and report of an unusual case
Giamarellou et al.	1984	In vitro synergistic activities of aminoglycosides and new beta-lactams against multiresistant Pseudomonas aeruginosa
US7026353B2 (en)	2006-04-11	Inhibition of Gram positive bacteria
UA42699C2 (uk)	2001-11-15	Бензоксазинонові сполуки, спосіб інгібування зворотної транскриптази, попередження або лікування, комбінації та фармацевтичні композиції
ES8502687A1 (es)	1985-01-16	Procedimiento para preparar derivados de 4-oxo-1,4-dihidroquinoleina.
Adler et al.	1986	Development of an improved selective medium for isolation of leptospires from clinical material
HUT60713A (en)	1992-10-28	Process for producing pharmaceutical compositions suitable for treating hiv infections and for producing their active ingredients
EP0734387A4 (de)	1997-03-05	Hiv-proteaseinhibitoren
Brogden et al.	2007	Antimicrobial activity of cathelicidins BMAP28, SMAP28, SMAP29, and PMAP23 against Pasteurella multocida is more broad-spectrum than host species specific
Chirino-Trejo et al.	2003	Antibiotic sensitivity and biochemical characterization of Fusobacterium spp. and Arcanobacterium pyogenes isolated from farmed white-tailed deer (Odocoileus virginianus) with necrobacillosis
Holmberg et al.	1977	Antimicrobial in vitro susceptibility of Actinomyces israelii and Arachnia propionica
Vanhoof et al.	1986	The comparative activity of pefloxacin, enoxacin, ciprofloxacin and 13 other antimicrobial agents against enteropathogenic microorganisms
Lai	1993	A cancer patient with central venous catheter-related sepsis caused by Tsukamurella paurometabolum (Gordona aurantiaca)
Yemul et al.	1981	Bacteriology of burns
Holton et al.	1991	Mycobacterium haemophilum infection in a patient with AIDS
DE68910397T2 (de)	1994-04-21	Vorbeugung oder Beseitigung von Mycoplasmakontamination in pflanzlichen oder tierischen Zellkulturen.
Gadberry et al.	1984	Pasteurella pneumotropica isolated from bone and joint infections
Goetz et al.	1979	Effects of some antibiotics on the growth of human diploid skin fibroblasts in cell culture
ATE260097T1 (de)	2004-03-15	Hopfensäuren zur hemmung von staphylococcus aureus
Callapina et al.	2001	Systemic and intracerebral infections of mice with Listeria monocytogenes successfully treated with linezolid
Clark et al.	1961	Multiplication of Coagulase-Positive Staphylococci in Grade a Raw Milk Samples1, 2
KR102716814B1 (ko)	2024-10-16	과수 화상병에 특이적인 신규 박테리오파지 및 이의 이용
Berger et al.	1978	Penetration of clindamycin into decubitus ulcers
Walsh et al.	1993	Rhodococcus

Legal Events

Date	Code	Title	Description
1993-05-15	UEP	Publication of translation of european patent specification
1997-11-15	REN	Ceased due to non-payment of the annual fee